The Effect of PAS on the Pharmacokinetics of Tenofovir in Healthy Subjects
NCT03070405
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Healthy Volunteers
Interventions
DRUG:
Tenofovir disoproxil fumarate 300mg
DRUG:
Para-aminosalicylic acid Ca granule 5.28 g
Sponsor
Inje University